Mitoxantrone Chemotherapy: Uses, Dosage, and Side Effects Explained

Summary of Key Points

Mitoxantrone is a prescription medication used to treat various cancers and multiple sclerosis (MS). It works by slowing the growth of cancer cells and suppressing the immune system in MS. Administered via injection, typically in a hospital or clinic, it may cause side effects, so it’s essential to follow your doctor’s instructions closely.

Names of Medication

US Brand Name: Novantrone

Generic Name: Mitoxantrone

The generic name refers to the active ingredient, while the brand name is assigned by the manufacturer. In this case, Mitoxantrone is the generic name.

Pharmacologic Category

Mitoxantrone belongs to the following pharmacologic categories:

1. Antineoplastic Agent
2. Immunosuppressant
3. Topoisomerase II Inhibitor

Mitoxantrone Dosage

Mitoxantrone is used to treat several conditions, each with its own recommended dosage. Always follow your doctor’s instructions and never adjust your dose without consulting them. If you have questions about your treatment, you can schedule a telemedicine appointment with one of our providers.

Mitoxantrone for Multiple Sclerosis (MS)

Dosage: 12 mg/m² by intravenous (IV) infusion every 3 months.

Duration: Treatment is typically limited to 2-3 years due to the risk of heart damage.

Mitoxantrone for Prostate Cancer

Dosage: 12-14 mg/m² by IV infusion every 21 days, often combined with corticosteroids like prednisone.

Duration: Treatment continues until disease progression or unacceptable toxicity occurs.

Mitoxantrone for Leukemia (Acute Myeloid Leukemia – AML)

Dosage: 12 mg/m² by IV infusion daily for 3 days, usually combined with other chemotherapy agents.

Duration: Treatment cycles may be repeated based on response and tolerance.

Mitoxantrone for Breast Cancer

Dosage: 12-14 mg/m² by IV infusion every 21 days, often in combination with other chemotherapy drugs.

Duration: Treatment continues until disease progression or unacceptable toxicity occurs.

Mitoxantrone for Bladder Cancer

Dosage: 12-14 mg/m² by IV infusion every 21 days.

Duration: Treatment duration depends on response to therapy and side effects.

Mitoxantrone for Ovarian Cancer

Dosage: 12-14 mg/m² by IV infusion every 21 days.

Duration: Treatment continues based on response and tolerance.

Mitoxantrone for Non-Hodgkin Lymphoma

Dosage: 12-14 mg/m² by IV infusion every 21 days.

Duration: Treatment cycles may be repeated based on response and tolerance.

Mitoxantrone for Neuroblastoma

Dosage: 12 mg/m² by IV infusion every 21 days, often in combination with other chemotherapy agents.

Duration: Treatment continues until disease progression or unacceptable toxicity occurs.

Mitoxantrone for Chronic Myeloid Leukemia (CML)

Dosage: 12 mg/m² by IV infusion every 21 days.

Duration: Treatment continues based on response and tolerance.

Dosage Forms and Strengths

Mitoxantrone is available in the following dosage form:

1. Injection: 2 mg/mL solution in a 10 mL vial

Mitoxantrone Injection Administration Instructions

Mitoxantrone is administered by intravenous (IV) infusion, typically in a hospital or clinic. It’s important to follow your healthcare provider’s instructions carefully. The medication is given slowly over 5 to 15 minutes. You will be monitored closely during and after the infusion for any side effects. Be sure to attend all scheduled appointments for your infusions and follow-up care.

Mitoxantrone Side Effects and Adverse Reactions

Like all medications, Mitoxantrone can cause side effects. Some may be mild, while others can be more serious. Report any side effects to your healthcare provider immediately. If you experience severe reactions, seek medical attention right away.

Common Side Effects (Occurring in more than 10% of patients)

1. Nausea and Vomiting: Feeling sick or vomiting is common, but medications can help manage these symptoms.
2. Hair Loss: Temporary hair loss may occur, but hair usually grows back after therapy ends.
3. Fatigue: Feeling unusually tired is common, especially after infusions.

Less Common Side Effects (Occurring in 1-10% of patients)

1. Heart Problems: Mitoxantrone can damage the heart, potentially leading to heart failure. Your doctor will monitor your heart function during treatment.
2. Infections: The medication can lower your white blood cell count, increasing the risk of infections. Report any signs of infection, such as fever or chills, to your doctor immediately.

Rare Side Effects (Occurring in less than 1% of patients)

1. Secondary Leukemia: In rare cases, Mitoxantrone can increase the risk of developing another type of leukemia. Your doctor will discuss this risk with you.

Contraindications for Mitoxantrone

A contraindication is a specific condition where a medication should not be used because it may be harmful. If you have any of the following conditions, Mitoxantrone may not be safe for you. Discuss these with your healthcare provider.

1. Severe liver disease: Mitoxantrone is processed by the liver, and if your liver isn’t functioning well, the drug can accumulate to dangerous levels.
2. Heart failure or other heart conditions: Mitoxantrone can damage the heart, especially in patients with pre-existing heart problems. If you have a history of heart disease, your doctor may recommend an alternative treatment.
3. Low white blood cell count (neutropenia): Mitoxantrone can further suppress your immune system, increasing the risk of serious infections.
4. Pregnancy: Mitoxantrone can harm an unborn baby. If you are pregnant or planning to become pregnant, this medication is not recommended (see more details below).
5. Allergic reaction to Mitoxantrone: If you’ve had an allergic reaction to Mitoxantrone or any of its components, you should not take this medication.

Drug to Drug Interactions

Mitoxantrone can interact with other medications, potentially increasing side effects or reducing its effectiveness. It’s important to inform your healthcare provider about all the medications you are taking, including over-the-counter drugs and supplements. Some known interactions include:

1. Cyclophosphamide (Cytoxan): Using this chemotherapy drug alongside Mitoxantrone may increase the risk of heart damage.
2. Doxorubicin (Adriamycin): Combining these chemotherapy agents can heighten the risk of heart toxicity.
3. Trastuzumab (Herceptin): This breast cancer treatment can also raise the likelihood of heart problems when used with Mitoxantrone.
4. Live vaccines: Vaccines such as the measles, mumps, and rubella (MMR) vaccine should be avoided while taking Mitoxantrone, as it can weaken the immune system, increasing the risk of infection from the vaccine.

Mitoxantrone in Pregnancy

Is it safe to take Mitoxantrone when pregnant?

No, Mitoxantrone is not safe during pregnancy. It is classified as a pregnancy category D drug, meaning it has been shown to harm an unborn baby. If you are pregnant or planning to become pregnant, discuss alternative treatments with your healthcare provider. If you become pregnant while taking Mitoxantrone, contact your doctor immediately.

Mitoxantrone while Breastfeeding

Is it safe to take Mitoxantrone while breastfeeding?

No, Mitoxantrone is not recommended while breastfeeding. The drug can pass into breast milk and may harm a nursing baby. If you are breastfeeding or plan to breastfeed, consult your healthcare provider to explore safer alternatives.

Estimated Cost of Mitoxantrone

The cost of Mitoxantrone can vary depending on your location and pharmacy. Without insurance, a 30-day supply using a GoodRx coupon is estimated to cost between $1,200 and $2,000. Prices may differ, so it’s a good idea to check with your pharmacy or use a prescription discount service like GoodRx to find the best price available.

Possible Alternatives to Mitoxantrone

If Mitoxantrone is not suitable for you, there are alternative treatments available depending on your condition. Always consult your healthcare provider before making any changes to your treatment plan. Our telemedicine providers are also available to discuss these options with you.

1. Multiple sclerosis: Alternatives include interferon beta (Avonex, Rebif), glatiramer acetate (Copaxone), or newer oral treatments like fingolimod (Gilenya). Lifestyle changes, such as regular exercise, a balanced diet, and stress management, can also help manage symptoms.
2. Prostate cancer: Alternatives include hormone therapy (e.g., leuprolide or goserelin), radiation therapy, or surgery. Maintaining a healthy diet and regular exercise may also support prostate cancer management.
3. Leukemia: Other chemotherapy drugs, targeted therapies (e.g., imatinib for chronic myeloid leukemia), or bone marrow transplants may be considered. Your doctor will recommend the best course of action based on your specific type of leukemia.
4. Non-Hodgkin lymphoma: Treatment options include chemotherapy, radiation therapy, or targeted therapies like rituximab (Rituxan). A healthy lifestyle, including a nutritious diet and regular physical activity, may support your overall health during treatment.
5. Breast cancer: Alternatives include other chemotherapy agents, hormone therapy (e.g., tamoxifen), or targeted therapies like trastuzumab (Herceptin). Maintaining a healthy weight, staying active, and limiting alcohol intake can help reduce the risk of recurrence.
6. Bladder cancer: Surgery, radiation therapy, or immunotherapy (e.g., BCG vaccine) may be considered as alternatives. Drinking plenty of water and avoiding smoking can help lower the risk of bladder cancer.
7. Ovarian cancer: Other chemotherapy drugs, such as carboplatin or paclitaxel, may be used. Surgery is often a key part of the treatment plan. Maintaining a healthy lifestyle and attending regular check-ups are important for managing ovarian cancer.
8. Neuroblastoma: Treatment options may include surgery, radiation therapy, or other chemotherapy agents. Your healthcare provider will determine the best treatment based on the stage and severity of the disease.
9. Acute myeloid leukemia (AML): Alternatives include other chemotherapy drugs like cytarabine or targeted therapies. In some cases, a bone marrow transplant may also be considered.
10. Chronic myeloid leukemia (CML): Targeted therapies such as imatinib (Gleevec) or dasatinib (Sprycel) are commonly used. Your healthcare provider will help determine the most appropriate treatment for your specific case.

Recent Updates on Mitoxantrone Research

Recent studies have focused on the long-term effects of Mitoxantrone, particularly its impact on heart health. Research indicates that patients treated with Mitoxantrone for multiple sclerosis or cancer may face an increased risk of heart problems, even years after completing treatment. As a result, there is now stricter monitoring of heart function during and after Mitoxantrone therapy.

Additionally, ongoing research is exploring the combination of Mitoxantrone with newer targeted therapies to improve cancer treatment outcomes. These studies aim to reduce the side effects of chemotherapy while enhancing its effectiveness. If you have questions about how this research may affect your treatment plan, our telemedicine providers are available to discuss the latest findings with you.

James Kingsley

Learn More